Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 11.736.17-0.4011.4510.95

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.73 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202411.73
Mar20236.17
Mar2022-0.40
Mar202111.45
Mar202010.95

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2024 11.73
90.11
Mar2023 6.17
Positive
Mar2022 -0.4
Negative
Mar2021 11.45
4.57
Mar2020 10.95 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹6,016.5 Cr -2.1% -5.9% -24.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-2.1%

-5.9%

-24.8%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses